Evidence map›Paper›PMID 39454003›Full record

ArticleScience advances2024

Efficient electroporation in primary cells with PEDOT:PSS electrodes.

Asmaysinh A Gharia, Clinton J Bradfield, Elise P W Jenkins, Iain D C Fraser, George G Malliaras

Abstract read
In one paragraph

Article in Science advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Asmaysinh A GhariaElectrical Engineering Division, Department of Engineering, University of Cambridge, Cambridge, UK.ORCID 0000-0003-0805-4145
Clinton J BradfieldLaboratory of Immune System Biology, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0001-6410-3517
Elise P W JenkinsElectrical Engineering Division, Department of Engineering, University of Cambridge, Cambridge, UK.ORCID 0009-0008-6240-8964
Iain D C FraserLaboratory of Immune System Biology, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0003-2272-3907
George G MalliarasElectrical Engineering Division, Department of Engineering, University of Cambridge, Cambridge, UK.ORCID 0000-0002-4582-8501

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Precise and efficient delivery of macromolecules into cells enhances basic biology research and therapeutic applications in cell therapies, drug delivery, and personalized medicine. While pulsed electric field electroporation effectively permeabilizes cell membranes to deliver payloads without the need for toxic chemical or viral transduction agents, conventional bulk electroporation devices face major challenges with cell viability and heterogeneity due to variations in fields generated across cells and electrochemistry at the electrode-electrolyte interface. Here, we introduce the use of microfabricated electrodes based on the conducting polymer poly(3,4-ethylenedioxythiophene) doped with polystyrene sulfonate (PEDOT:PSS), which substantially increases cell viability and transfection efficiency. As a proof of concept, we demonstrate the enhanced delivery of Cas9 protein, guide RNA, and plasmid DNA into cell lines and primary cells. This use of PEDOT:PSS enables rapid modification of difficult-to-transfect cell types to accelerate their study and use as therapeutic platforms.

Indexed as

Bridged Bicyclo Compounds, HeterocyclicElectrodesElectroporationPolymersPolystyrenesAnimalsCell SurvivalHumansMiceTransfectionBridged Bicyclo Compounds, Heterocyclicpoly(3,4-ethylene dioxythiophene)PolymersPolystyrenespolystyrene sulfonic acid

Identifiers

PMID39454003
PMCPMC11506140

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.